Ladenburg Thalmann Downgrades ReShape Lifesciences Inc (RSLS) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
ReShape Lifesciences Inc. (RSLS) Prices 1M Share Registered Direct Offering at $0.60/Sh
August 2, 2018 7:55 AM EDTReShape Lifesciences Inc. (NASDAQ: RSLS) today announced that it has entered into definitive agreements with several institutional investors for the purchase of 1,000,000 shares of its common stock, at a purchase price per share of $0.60, for gross proceeds of approximately $0.6 million, in a registered direct offering.... More
